Viatris Inc Analysts Weigh PostMerger Strategy and Generic Drug Portfolio Outlook
Tamil Nadu Braces for Extended Heatwave With Temperatures Exceeding 40C Health Advisory Issued
Caseys General Stores CASY Gains Attention After Jim Cramers Hidden Gem Endorsement
Q4 Earnings Season Shows Mixed Results Across Key Sectors
Gold Price Outlook 2026 Analysts Weigh Potential Trajectory Amid Economic Uncertainty
Arvind Sanger Cautiously Optimistic on India Eyes Earnings Revival Amid Global Liquidity Shift
Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates
NXST Q1 2026 Earnings Strong EPS Beat Amidst Modest Stock Decline as Nexstar Outperforms Estimates
Avita Medical Q1 2026 Earnings EPS Miss Clouds Progress Stock Gains
Tenaris TS Q1 2026 Earnings EPS Beat Drives Upbeat Outlook Yet Shares Slip
FTK Q1 2026 Earnings EPS Misses Estimates as Stock Declines
Fractyl Health Inc GUTS Q1 2026 Earnings Narrower Loss Surprises Stock Slides
Grande Group Limited GRAN Gains 396 as Price Tests Key Resistance at 110
Integer Holdings ITGR Edges Lower as Stock Holds Above Key Support Zone
GFL Environmental GFL Dips 169 Testing Key Support as Sector Sentiment Weighs
Allogene Therapeutics Edges Higher Testing Key Resistance at 21
Nextdoor Holdings NXDR Slips Near Support as Trading Volatility Persists
Automation Threatens 69 of Jobs in India World Bank Data Suggests
Enbridge Q1 2026 Earnings Earnings Beat Drives Modest Stock Gain Amid Stable Operations
Unicycive Therapeutics UNCY Edges Higher as Stock Tests Key Resistance Near 746
Jim Cramers PreCrash Comments on Intuit What Investors Should Know
Russias Yolka Interceptor Faces Operational Hurdles Amid Drone Warfare in Ukraine
The 530 Orange Juice A Case Study in Rising Supermarket Prices
SP 500 Edges Higher as Healthcare Tech Lead Communication Services Lags
UKGulf Trade Deal Bahrain Minister Hails Monumental Achievement in Bilateral Relations
US April Payrolls Beat Expectations But Report Flags Economic Concerns
Financial Crossroads Newly Separated Dad Faces Rent vs Buy Dilemma